Analysts expect Rhythm Pharmaceuticals, Inc. to report revenue of 90.63 M for Q3 26, against a range of 85.26 M to 96.00 M. The most recent reported quarter, Q2 26, came in at 71.25 M, a 9.1% beat against the 65.28 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 33.25 M | 41.83 M | 32.70 M | 48.50 M | 51.30 M | 57.25 M | 60.11 M | 71.25 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 33.62 M | 39.17 M | 45.72 M | 44.28 M | 51.49 M | 57.03 M | 62.96 M | 67.49 M | 96.00 M | 101.21 M | 109.46 M | 140.49 M | 158.35 M | 179.35 M | 177.57 M | 222.66 M | ||||||||||
| Low Estimate | 27.56 M | 34.20 M | 37.84 M | 39.70 M | 43.47 M | 50.89 M | 54.14 M | 63.07 M | 85.26 M | 88.91 M | 100.34 M | 115.56 M | 131.25 M | 148.34 M | 161.02 M | 195.55 M | ||||||||||
| Consensus Estimate | 30.59 M | 36.69 M | 41.78 M | 41.99 M | 47.48 M | 53.96 M | 58.55 M | 65.28 M | 90.63 M | 95.06 M | 104.90 M | 128.03 M | 144.80 M | 163.84 M | 169.29 M | 209.11 M |
Analysts expect Rhythm Pharmaceuticals, Inc. to report earnings per share of -0.68 for Q3 26, against a range of -0.71 to -0.65. The most recent reported quarter, Q2 26, came in at -0.73, a 15.1% beat against the -0.86 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.73 | -0.72 | -0.81 | -0.75 | -0.82 | -0.73 | -0.83 | -0.73 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.70 | -0.60 | -0.59 | -0.65 | -0.74 | -0.71 | -0.72 | -0.79 | -0.65 | -0.70 | -0.60 | -0.41 | -0.37 | -0.35 | 0.39 | 0.61 | ||||||||||
| Low Estimate | -0.82 | -0.74 | -0.73 | -0.75 | -0.78 | -0.79 | -0.86 | -0.93 | -0.71 | -0.82 | -0.66 | -0.49 | -0.41 | -0.41 | 0.33 | 0.57 | ||||||||||
| Consensus Estimate | -0.76 | -0.67 | -0.66 | -0.70 | -0.76 | -0.75 | -0.79 | -0.86 | -0.68 | -0.76 | -0.63 | -0.45 | -0.39 | -0.38 | 0.36 | 0.59 |
Pull Wall Street consensus for Rhythm Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RYTM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RYTM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RYTM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();